RKDA · Arcadia Biosciences, Inc.
$0.50
-0.02 (-2.97%)
At close · Sep 1
Going-concern doubt
— flagged Aug 13, 2026
Substantial doubt about the company's ability to continue as a going concern.
“With cash and cash equivalents of $4.2 million as of June 30, 2026, the Company believes that its existing cash and cash equivalents will not be sufficient to meet its anticipated cash requirements for at least the next 12 months from the issuance date of these financial statements, and thus raises substantial doubt about the Company's ability to continue as a going concern. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.”View the 10-Q filed Aug 13, 2026
Market Cap
$1.28M
Shares
2.41M
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Revenue
$4.86M
-3.7%
FY2025
Net Income
-$2.34M
+66.8%
FY2025
Gross Margin
36.23%
-5pp
FY2025
Operating Margin
-51.46%
+20.8pp
FY2025
Diluted EPS
-$1.71
+66.9%
FY2025
Operating Cash Flow
-$4.7M
+51.2%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| $4.75M | $4.86M | $5.05M | $4.45M | $7.42M | $6.78M | $8.03M | $1.17M | $1.46M | $4.03M | $3.19M | $5.41M | $6.98M | |
| $12K | $221K | $782K | $695K | $289K | -$20K | — | — | — | — | — | — | — | |
| $3.1M | $3.1M | $2.96M | $2.17M | $6.1M | $8.71M | $5.2M | — | — | $283K | $895K | $892K | $2M | |
| $1.64M | $1.76M | $2.08M | $2.28M | $1.32M | -$1.93M | $2.84M | — | — | $3.74M | $2.29M | $4.52M | $4.99M | |
| — | 36.23% | 41.27% | 51.19% | 17.75% | -28.44% | 35.29% | — | — | 92.97% | 71.93% | 83.52% | 71.4% | |
| — | $9000 | $53K | $64K | $1.51M | $3.89M | $7.96M | $7.1M | $6.07M | $7.41M | $8.66M | $8.97M | $10.01M | |
| $5.45M | $7M | $9.64M | $8.23M | $15.04M | $22.94M | $16.47M | $13.57M | $11.6M | $10.65M | $12.25M | $11.12M | $10.13M | |
| — | — | — | $0 | $40K | $116K | $30K | — | — | — | — | — | — | |
| $164K | — | — | — | — | — | — | — | $154K | $279K | $304K | $294K | $358K | |
| $25.99M | — | — | — | — | — | $20.81M | $20.55M | $18.33M | $18.34M | $21.81M | $20.98M | $22.14M | |
| $8.55M | $7.36M | $8.69M | $10.56M | $21.43M | $42.31M | $20.81M | — | — | — | — | — | — | |
| -$3.8M | -$2.5M | -$3.65M | -$6.1M | -$14.01M | -$35.53M | -$12.78M | -$19.38M | -$16.87M | -$14.32M | -$18.62M | -$15.56M | -$15.15M | |
| — | -51.46% | -72.31% | -137% | -188.82% | -523.98% | -159.05% | -1657.91% | -1152.32% | -355.56% | -584.07% | -287.46% | -217.03% | |
| -$19.58M | — | — | — | — | — | — | — | -$16.72M | -$14.04M | -$18.32M | -$15.27M | -$14.8M | |
| $12K | — | — | — | — | $20K | $47K | $5000 | — | $747K | $1.32M | $2.66M | $1.39M | |
| -$3.05M | $2.31M | $31K | $48K | $9000 | $10.11M | $740K | $466K | $394K | $281K | $340K | $521K | -$597K | |
| — | — | — | — | — | — | — | — | — | — | — | $0 | -$932K | |
| — | -$2.33M | -$4.31M | -$5.32M | -$10.81M | -$16.13M | -$6.15M | -$28.87M | -$13.47M | -$15.68M | -$19.6M | -$17.93M | -$18.08M | |
| — | $8000 | $8000 | $8000 | $14K | $2000 | -$124K | $2000 | $10K | $26K | $25K | $26K | $263K | |
| -$11.09M | -$2.34M | -$7.04M | -$13.98M | -$15.38M | -$14.66M | -$4.66M | -$28.81M | -$13.48M | -$15.71M | -$19.62M | -$17.96M | -$18.34M | |
| — | -48.15% | -139.5% | -313.9% | -207.28% | -216.22% | -57.94% | -2464.07% | -920.77% | -390.14% | -615.56% | -331.66% | -262.66% | |
| — | — | $0 | -$5000 | -$236K | -$1.47M | -$1.37M | -$68K | — | — | — | — | — | |
| — | — | — | — | — | — | — | — | — | — | -$19.62M | -$20.73M | -$22.08M | |
| — | -$2.34M | -$7.14M | -$13.88M | -$15.38M | -$14.66M | -$4.66M | -$28.8M | -$13.48M | -$15.69M | -$19.53M | -$20.84M | -$22.08M | |
| USD/shares | -$4.55 | -$1.71 | -$5.17 | -$11.29 | -$25.65 | -$27.56 | — | — | — | — | — | — | — |
| USD/shares | -$4.55 | -$1.71 | -$5.17 | -$11.29 | -$25.65 | -$27.56 | — | — | — | — | — | — | — |
| shares | — | 1.37M | 1.36M | 1.24M | 599.39K | 532.02K | 248.98K | 159.08K | 94.16K | 53.91K | 55.46K | 713.98K | 51.53K |
| shares | — | 1.37M | 1.36M | 1.24M | 599.39K | 532.02K | 248.98K | 159.08K | 94.16K | 53.91K | 55.46K | 713.98K | 51.53K |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against peers, and each ratio recomputed as of past filing dates.
Valuation
EV/Revenue
—
Packaged Foods median 1.36×
EV/EBIT
—
Packaged Foods median 14.91×
P/E (TTM)
—
Packaged Foods median 15.58×
Valuation over time computed as of each quarter's filing date
Revenue Breakdown
Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.
Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.
By Geography (USD)
| Component | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| United States | $4,858,000 | $4,903,000 | $4,156,000 | $6,298,000 | $6,003,000 | $761,000 |
| Argentina | $0 | $26,000 | $0 | $862,000 | $26,000 | $6,681,000 |
| Canada | $0 | $109,000 | $291,000 | $194,000 | $503,000 | $354,000 |
| India | $0 | $7,000 | $7,000 | $7,000 | $7,000 | $100,000 |
| Austria | — | — | — | — | — | $32,000 |
| Germany | — | — | — | $57,000 | — | — |
| Spain | — | — | — | — | $225,000 | — |
| United Kingdom | — | — | — | — | $16,000 | — |
| Africa | — | — | — | — | — | $106,000 |
By Product & Service (USD)
| Component | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Product | $4,858,000 | $5,012,000 | $4,437,000 | $6,422,000 | $6,587,000 | $1,044,000 |
| License | $0 | $7,000 | $17,000 | $879,000 | $17,000 | $6,801,000 |
| Royalty | $0 | $26,000 | $0 | $117,000 | $176,000 | $83,000 |
| Contract Research and Government Grants | — | — | — | — | — | $106,000 |
Key facts
CIK
1469443
CUSIP
039014303
13F (30d)
16 filings
16 filers
Visit website
Investor relations